Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $109M
Founded date: 2018
Investors 4
Date | Name | Website |
- | KdT Ventur... | kdtvc.com |
08.05.2021 | Lux Capita... | luxcapital... |
- | Sahsen Ven... | sahsen.com |
12.05.2021 | GV | gv.com |
Funding Rounds 2
Date | Series | Amount | Investors |
07.05.2021 | Series A | $100M | - |
11.05.2020 | Seed | $9M | - |
Mentions in press and media 8
Date | Title | Description | Source |
22.05.2023 | Dyno Therapeutics Launches the Dyno bCap 1 Capsid Product, a... | – Dyno bCap 1 exhibits 100x improvement versus AAV9 in delivery to the central nervous system (CNS) ... | aithority.... |
07.05.2021 | Dyno Therapeutics gets $100M in a16z-led round | Dyno Therapeutics, a biotech startup that's applying AI to gene therapy, has announced a $100 millio... | pitchbook.... |
06.05.2021 | Dyno grabs $100M to expand tech, build team, ink more gene t... | Dyno Therapeutics emerged last year with a modest seed round and Big Pharma partnerships to fuel its... | fiercebiot... |
06.05.2021 | Dyno Therapeutics Closes $100 Million Series A Financing Led... | Dyno Therapeutics, Inc., a biotechnology company applying artificial intelligence (AI) to gene thera... | marketscre... |
06.05.2021 | Dyno Therapeutics Closes $100M Series A Financing | Dyno Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company applying artificial intellig... | finsmes.co... |
19.10.2020 | AI drug-discovery firm lands first partnership | Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Healt... | medcitynew... |
11.05.2020 | Dyno Therapeutics Raises $9M in Seed Financing | Dyno Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company applying artificial intellig... | finsmes.co... |
- | AI drug-discovery firm lands first partnership | Roche Group subsidiary Genentech has tapped a startup drug-discovery firm to find potential drug can... | medcitynew... |